Acute hepatitis C in persons infected with the human immunodeficiency virus (HIV): The

Table 1 Baseline characteristics of the 319 HIV patients with acute hepatitis C^a.

Age [years] (range)	40 (20-69)
Sex, male [%]	100
HCV transmission risk MSM, n (%)	296 (93)
Time since HIV infection [years] (range)	5.5 (0-22.4)
CD4 count [cells/μl] (range)	461 (55-1331)
HIV viral load [copies/mL] (range)	110 (50-10 × 10⁶)
cART, n (%)	200 (63)
CDC stage C, n (%)	59 (18)
HCV RNA [IU/mL] (range)	1.2 × 10⁶ (33-676 × 10⁶)
HCV genotype 1, n (%)	222 (70)
Maximum ALT level at diagnosis ^b [IU/mL] (range)	420 (19-4217)
Symptomatic hepatitis, as indicated by physician, n (%)	83 (26)
Time to treatment ^c , weeks (IQR)	12.6 (4.7-24.4)
Duration of therapy, weeks (IQR)	33 (24.1-49.9)

^avalues are given as median unless otherwise indicated.
^bMaximum median alanin aminotransferase (ALT) level is the maximum increase in Alt measured at the time of diagnosis.
^ctime to treatment is the time between diagnosis and first dose given. MSM, men who have sex with men. CDC, Center for disease control and prevention.

ISSN: 2047-783X